Financials PT UBC Medical Indonesia Tbk

Equities

LABS

ID1000205305

Medical Equipment, Supplies & Distribution

End-of-day quote INDONESIA S.E. 23:00:00 14/07/2024 BST 5-day change 1st Jan Change
170 IDR -13.27% Intraday chart for PT UBC Medical Indonesia Tbk 0.00% 0.00%

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 129,960 93,292 136,699
EBITDA 1 11,009 12,187 15,402
EBIT 1 3,191 3,398 5,844
Operating Margin 2.46% 3.64% 4.27%
Earnings before Tax (EBT) 1 2,682 4,528 6,231
Net income 1 308.3 2,834 2,190
Net margin 0.24% 3.04% 1.6%
EPS - - 673.7
Free Cash Flow - -22,351 -34,775
FCF margin - -23.96% -25.44%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 19/06/24 19/06/24 19/06/24
1IDR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 14,477 18,703 37,805
Net Cash position 1 - - -
Leverage (Debt/EBITDA) 1.315 x 1.535 x 2.454 x
Free Cash Flow - -22,351 -34,775
ROE (net income / shareholders' equity) - 10% 4.52%
ROA (Net income/ Total Assets) - 2.08% 2.72%
Assets 1 - 135,951 80,640
Book Value Per Share - - 15,188
Cash Flow per Share - - 1,113
Capex 1 11,710 3,280 19,405
Capex / Sales 9.01% 3.52% 14.2%
Announcement Date 19/06/24 19/06/24 19/06/24
1IDR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. LABS Stock
  4. Financials PT UBC Medical Indonesia Tbk